Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 82

1.

Human melanoma brain metastases cell line MUG-Mel1, isolated clones and their detailed characterization.

Heitzer E, Groenewoud A, Meditz K, Lohberger B, Liegl-Atzwanger B, Prokesch A, Kashofer K, Behrens D, Haybaeck J, Kolb-Lenz D, Koefeler H, Riedl S, Schaider H, Fischer C, Snaar-Jagalska BE, de'Jong D, Szuhai K, Zweytick D, Rinner B.

Sci Rep. 2019 Mar 11;9(1):4096. doi: 10.1038/s41598-019-40570-1.

2.

Why local air pollution is more than daily peaks: modelling policies in a city in order to avoid premature deaths.

Behrens DA, Koland O, Leopold-Wildburger U.

Cent Eur J Oper Res. 2018;26(2):265-286. doi: 10.1007/s10100-018-0534-y. Epub 2018 Mar 28.

3.

Simulations of optically switchable molecular machines for particle transport.

Raeker T, Jansen B, Behrens D, Hartke B.

J Comput Chem. 2018 Jul 30;39(20):1433-1443. doi: 10.1002/jcc.25212. Epub 2018 Mar 24.

PMID:
29573268
4.

Azoles additively inhibit cytochrome P450 1 (EROD) and 19 (aromatase) in rainbow trout (Oncorhynchus mykiss).

Beijer K, Jönsson M, Shaik S, Behrens D, Brunström B, Brandt I.

Aquat Toxicol. 2018 May;198:73-81. doi: 10.1016/j.aquatox.2018.02.016. Epub 2018 Feb 21.

PMID:
29522952
5.

The deubiquitinating enzyme USP5 promotes pancreatic cancer via modulating cell cycle regulators.

Kaistha BP, Krattenmacher A, Fredebohm J, Schmidt H, Behrens D, Widder M, Hackert T, Strobel O, Hoheisel JD, Gress TM, Buchholz M.

Oncotarget. 2017 Aug 3;8(39):66215-66225. doi: 10.18632/oncotarget.19882. eCollection 2017 Sep 12.

6.

Animal models for personalized treatment options.

Fichtner I, Klinghammer K, Behrens D, Flechsig S, Rolff J, Becker M, Wulf-Goldenberg A, Stecklum M, Rivera M, Brzezicha B, Jandrig B, Hoffmann J.

Int J Clin Pharmacol Ther. 2017 Aug;55(8):698-700. doi: 10.5414/CPXCES15EA09. No abstract available.

PMID:
28696202
7.

Modelling for the proposed roll-out of the '111' service in Wales: a case study.

Tuson M, England T, Behrens D, Bowen R, Edwards D, Frankish J, Kay J.

Health Care Manag Sci. 2018 Jun;21(2):159-176. doi: 10.1007/s10729-017-9405-7. Epub 2017 Jun 2.

PMID:
28577263
8.

Acoustic startle modification as a tool for evaluating auditory function of the mouse: Progress, pitfalls, and potential.

Lauer AM, Behrens D, Klump G.

Neurosci Biobehav Rev. 2017 Jun;77:194-208. doi: 10.1016/j.neubiorev.2017.03.009. Epub 2017 Mar 19. Review.

9.

Pancreatic cancer models for translational research.

Behrens D, Walther W, Fichtner I.

Pharmacol Ther. 2017 May;173:146-158. doi: 10.1016/j.pharmthera.2017.02.013. Epub 2017 Feb 4. Review. No abstract available.

PMID:
28174092
10.

The impact of pH inhomogeneities on CHO cell physiology and fed-batch process performance - two-compartment scale-down modelling and intracellular pH excursion.

Brunner M, Braun P, Doppler P, Posch C, Behrens D, Herwig C, Fricke J.

Biotechnol J. 2017 Jul;12(7). doi: 10.1002/biot.201600633. Epub 2017 Feb 3.

PMID:
28078826
11.

Role of BCL9L in transforming growth factor-β (TGF-β)-induced epithelial-to-mesenchymal-transition (EMT) and metastasis of pancreatic cancer.

Sannino G, Armbruster N, Bodenhöfer M, Haerle U, Behrens D, Buchholz M, Rothbauer U, Sipos B, Schmees C.

Oncotarget. 2016 Nov 8;7(45):73725-73738. doi: 10.18632/oncotarget.12455.

12.

Screening of Conditionally Reprogrammed Patient-Derived Carcinoma Cells Identifies ERCC3-MYC Interactions as a Target in Pancreatic Cancer.

Beglyarova N, Banina E, Zhou Y, Mukhamadeeva R, Andrianov G, Bobrov E, Lysenko E, Skobeleva N, Gabitova L, Restifo D, Pressman M, Serebriiskii IG, Hoffman JP, Paz K, Behrens D, Khazak V, Jablonski SA, Golemis EA, Weiner LM, Astsaturov I.

Clin Cancer Res. 2016 Dec 15;22(24):6153-6163. Epub 2016 Jul 6.

13.

Comparative embryotoxicity and genotoxicity of the herbicide diuron and its metabolites in early life stages of Crassostrea gigas: Implication of reactive oxygen species production.

Behrens D, Rouxel J, Burgeot T, Akcha F.

Aquat Toxicol. 2016 Jun;175:249-59. doi: 10.1016/j.aquatox.2016.04.003. Epub 2016 Apr 4.

PMID:
27078212
14.

Comparison of mouse minimum audible angle determined in prepulse inhibition and operant conditioning procedures.

Behrens D, Klump GM.

Hear Res. 2016 Mar;333:167-178. doi: 10.1016/j.heares.2016.01.011. Epub 2016 Jan 22.

PMID:
26807797
15.

Predictive In Vivo Models for Oncology.

Behrens D, Rolff J, Hoffmann J.

Handb Exp Pharmacol. 2016;232:203-21. Review.

PMID:
26489829
16.

Comparison of the sensitivity of prepulse inhibition of the startle reflex and operant conditioning in an auditory intensity difference limen paradigm.

Behrens D, Klump GM.

Hear Res. 2015 Mar;321:35-44. doi: 10.1016/j.heares.2014.12.010. Epub 2015 Jan 8.

PMID:
25580004
17.

The nerve growth factor receptor CD271 is crucial to maintain tumorigenicity and stem-like properties of melanoma cells.

Redmer T, Welte Y, Behrens D, Fichtner I, Przybilla D, Wruck W, Yaspo ML, Lehrach H, Schäfer R, Regenbrecht CR.

PLoS One. 2014 May 5;9(5):e92596. doi: 10.1371/journal.pone.0092596. eCollection 2014. Erratum in: PLoS One. 2014;9(8):e105274.

18.

Iatrogenic lymphoproliferative disorder.

Nader K, Behrens DS, Leon CA, Schwarting R, Ferber A.

Am J Hematol. 2014 Jul;89(7):787-8. doi: 10.1002/ajh.23739. No abstract available.

19.

Preclinical study on combined chemo- and nonviral gene therapy for sensitization of melanoma using a human TNF-alpha expressing MIDGE DNA vector.

Kobelt D, Aumann J, Schmidt M, Wittig B, Fichtner I, Behrens D, Lemm M, Freundt G, Schlag PM, Walther W.

Mol Oncol. 2014 May;8(3):609-19. doi: 10.1016/j.molonc.2013.12.019. Epub 2014 Jan 18.

20.

The epidermal basement membrane is a composite of separate laminin- or collagen IV-containing networks connected by aggregated perlecan, but not by nidogens.

Behrens DT, Villone D, Koch M, Brunner G, Sorokin L, Robenek H, Bruckner-Tuderman L, Bruckner P, Hansen U.

J Biol Chem. 2012 May 25;287(22):18700-9. doi: 10.1074/jbc.M111.336073. Epub 2012 Apr 9.

21.

Three QTL in the honey bee Apis mellifera L. suppress reproduction of the parasitic mite Varroa destructor.

Behrens D, Huang Q, Geßner C, Rosenkranz P, Frey E, Locke B, Moritz RF, Kraus FB.

Ecol Evol. 2011 Dec;1(4):451-8. doi: 10.1002/ece3.17.

22.

Strengthening children's oral health: views from the field.

Behrens D, Lear JG.

Health Aff (Millwood). 2011 Nov;30(11):2208-13. doi: 10.1377/hlthaff.2011.0815.

PMID:
22068412
23.

Association between out-of-hospital emergency department transfer and poor hospital outcome in critically ill stroke patients.

Rincon F, Morino T, Behrens D, Akbar U, Schorr C, Lee E, Gerber D, Parrillo J, Mirsen T.

J Crit Care. 2011 Dec;26(6):620-5. doi: 10.1016/j.jcrc.2011.02.009. Epub 2011 May 18.

PMID:
21596517
24.

Lethal infection thresholds of Paenibacillus larvae for honeybee drone and worker larvae (Apis mellifera).

Behrens D, Forsgren E, Fries I, Moritz RF.

Environ Microbiol. 2010 Oct;12(10):2838-45. doi: 10.1111/j.1462-2920.2010.02257.x. Epub 2010 Jul 7.

PMID:
20545737
25.

Severe ceftriaxone-induced hemolysis complicated by diffuse cerebral ischemia in a child with sickle cell disease.

Schuettpelz LG, Behrens D, Goldsmith MI, Druley TE.

J Pediatr Hematol Oncol. 2009 Nov;31(11):870-2. doi: 10.1097/MPH.0b013e3181b7eda2.

PMID:
19829151
26.

Health-care reform and school-based health care.

Lear JG, Barnwell EA, Behrens D.

Public Health Rep. 2008 Nov-Dec;123(6):704-8.

27.

Temporal and spatial dynamics of cerebral immune cell accumulation in stroke.

Gelderblom M, Leypoldt F, Steinbach K, Behrens D, Choe CU, Siler DA, Arumugam TV, Orthey E, Gerloff C, Tolosa E, Magnus T.

Stroke. 2009 May;40(5):1849-57. doi: 10.1161/STROKEAHA.108.534503. Epub 2009 Mar 5.

PMID:
19265055
28.

Discovery of a cytokine and its receptor by functional screening of the extracellular proteome.

Lin H, Lee E, Hestir K, Leo C, Huang M, Bosch E, Halenbeck R, Wu G, Zhou A, Behrens D, Hollenbaugh D, Linnemann T, Qin M, Wong J, Chu K, Doberstein SK, Williams LT.

Science. 2008 May 9;320(5877):807-11. doi: 10.1126/science.1154370.

29.

Loss of tumourigenicity of stably ERbeta-transfected MCF-7 breast cancer cells.

Behrens D, Gill JH, Fichtner I.

Mol Cell Endocrinol. 2007 Aug 15;274(1-2):19-29. Epub 2007 May 24.

PMID:
17597290
30.

Operating room briefings and wrong-site surgery.

Makary MA, Mukherjee A, Sexton JB, Syin D, Goodrich E, Hartmann E, Rowen L, Behrens DC, Marohn M, Pronovost PJ.

J Am Coll Surg. 2007 Feb;204(2):236-43. Epub 2006 Dec 8.

PMID:
17254927
31.
32.

An exploratory study of the cognitive, academic, and behavioral functioning of pediatric cardiothoracic transplant recipients.

Brosig C, Hintermeyer M, Zlotocha J, Behrens D, Mao J.

Prog Transplant. 2006 Mar;16(1):38-45.

PMID:
16676673
33.

Treatment of epistaxis in the emergency department.

Behrens DC.

Emerg Med J. 2006 Mar;23(3):241. No abstract available.

34.

Anti-cancer effects of bortezomib against chemoresistant neuroblastoma cell lines in vitro and in vivo.

Michaelis M, Fichtner I, Behrens D, Haider W, Rothweiler F, Mack A, Cinatl J, Doerr HW, Cinatl J Jr.

Int J Oncol. 2006 Feb;28(2):439-46.

PMID:
16391799
35.

Matrix metalloproteinase-activated doxorubicin prodrugs inhibit HT1080 xenograft growth better than doxorubicin with less toxicity.

Albright CF, Graciani N, Han W, Yue E, Stein R, Lai Z, Diamond M, Dowling R, Grimminger L, Zhang SY, Behrens D, Musselman A, Bruckner R, Zhang M, Jiang X, Hu D, Higley A, Dimeo S, Rafalski M, Mandlekar S, Car B, Yeleswaram S, Stern A, Copeland RA, Combs A, Seitz SP, Trainor GL, Taub R, Huang P, Oliff A.

Mol Cancer Ther. 2005 May;4(5):751-60.

36.

Reduction of sulfamethoxazole and dapsone hydroxylamines by a microsomal enzyme system purified from pig liver and pig and human liver microsomes.

Clement B, Behrens D, Amschler J, Matschke K, Wolf S, Havemeyer A.

Life Sci. 2005 May 27;77(2):205-19. Epub 2005 Feb 8.

PMID:
15862605
37.

Markov chain modeling of initiation and demand: the case of the U.S. cocaine epidemic.

Caulkins JP, Behrens DA, Knoll C, Tragler G, Zuba D.

Health Care Manag Sci. 2004 Nov;7(4):319-29.

PMID:
15717816
38.

Liposomal 4-hydroxy-tamoxifen: effect on cellular uptake and resulting cytotoxicity in drug resistant breast cancer cells in vitro.

Zeisig R, Teppke AD, Behrens D, Fichtner I.

Breast Cancer Res Treat. 2004 Oct;87(3):245-54.

PMID:
15528967
39.

A model of chaotic drug markets and their control.

Behrens DA, Caulkins JP, Feichtinger G.

Nonlinear Dynamics Psychol Life Sci. 2004 Jul;8(3):375-401.

PMID:
15233880
40.
41.

Effect of sialyl Lewis X-glycoliposomes on the inhibition of E-selectin-mediated tumour cell adhesion in vitro.

Zeisig R, Stahn R, Wenzel K, Behrens D, Fichtner I.

Biochim Biophys Acta. 2004 Jan 28;1660(1-2):31-40.

42.
43.

Allogeneic recombinant soluble MHC class I molecules modify urinary odor cues in rats.

Janssen E, Göhlen B, Behrens D, Richter K, Zavazava N.

Physiol Behav. 2001 Jan;72(1-2):107-14.

PMID:
11239987
44.

Reduction of amphetamine hydroxylamine and other aliphatic hydroxylamines by benzamidoxime reductase and human liver microsomes.

Clement B, Behrens D, Möller W, Cashman JR.

Chem Res Toxicol. 2000 Oct;13(10):1037-45.

PMID:
11080052
45.
46.

High Throughput Quantitation of cAMP Production Mediated by Activation of Seven Transmembrane Domain Receptors.

Kariv I I, Stevens ME, Behrens DL, Oldenburg KR.

J Biomol Screen. 1999;4(1):27-32.

PMID:
10838409
47.

Sporadic chromosome abnormalities in human lymphocytes and previous exposure to chemicals.

Ford JH, Behrens D, McCarthy C, Mills K, Thomas P, Wilkin HB.

Cytobios. 1998;96(383):179-92.

PMID:
10664678
48.

A dynamic model of drug initiation: implications for treatment and drug control.

Behrens DA, Caulkins JP, Tragler G, Haunschmied JL, Feichtinger G.

Math Biosci. 1999 Jun;159(1):1-20.

PMID:
10361802
49.

Continent ileostomy can be offered as an option to patients who fail the ileal pouch-anal anastomosis (IPAA)

Behrens DT, Paris M, Luttrell J.

Dis Colon Rectum. 1999 May;42(5):686. No abstract available.

PMID:
10344696
50.

Conversion of failed ileal pouch-anal anastomosis to continent ileostomy.

Behrens DT, Paris M, Luttrell JN.

Dis Colon Rectum. 1999 Apr;42(4):490-5; discussion 495-6.

PMID:
10215050

Supplemental Content

Loading ...
Support Center